ASLAN Pharmaceuticals will focus on clinical development of varlitinib while BioGenetics will obtain the necessary regulatory approvals for the use of the drug in South Korea.
Using bispecific T-cell engager technology, or BiTE, researchers in Japan have found that the cancer-killing activity of T-cells in tumors can be estimated from T-cells in the blood.
A research group has found that Chinese who consumed larger amounts of onions and garlic had a lower risk of being diagnosed with colorectal cancer.
The treatment method, which relies on electric fields to destroy tumors, can now be used to treat patients in Hong Kong diagnosed with an aggressive type of brain cancer.
Lenvatinib mesylate was shown to improve overall survival in patients with unresectable liver cancer.